Abstract
Premenstrual dysphoric disorder (PMDD) is a complex and disabling condition that affects around 3-8% of women. Symptoms associated with the disorder cause debilitating emotional states, including depression, anxiety, and episodes of psychosis, as well as impaired quality of life in women, poor occupational productivity, absences from work/school, higher medical bills, and suicidal ideations. Previous studies have estimated that about 89% of women who meet the criteria have not been diagnosed. This document delves into risk factors for the development of PMDD, the limitations in the diagnosis process and its treatments, since despite being recognized by the American Psychological Association (APA) and the World Health Organization ( WHO), PMDD continues to struggle to gain momentum in society. The high prevalence and lack of etiological knowledge shows the need to continue researching and raising awareness about this disorder.